Innate Pharma S.A.
ENXTPA:IPH
2.41
+ 0.07€ (2.99%)
2.41
+ 0.07€ (2.99%)
End-of-day quote: 05/17/2024

IPH - Innate Pharma Stock Prediction 2025 - 2030

18 years of reliable Innate Pharma stock forecast. The Wall Street analysts predict Outperform for IPH. See at a glance whether ENXTPA:IPH will rise in the future.

0.00€
Forecast 2023
2.79€
Forecast 2025
4.36€
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
0.00€
Forecast 2025
2.79€
Forecast 2030
4.36€
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.66
Price-to-book Ratio
3.77
Market Cap
0.20B
TEV
0.14 B
Dividend
0.00€
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
6.32€
Country

Innate Pharma Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Innate Pharma Stock Forecast 2023

7.00€

In the last five quarters, Innate Pharma’s Price Target has risen from 6.23€ to 6.32€ - a 1.44% increase. Two analysts predict that Innate Pharma’s share price will increase in the coming year, reaching 7.00€. This would represent an increase of 10.76%.

190.46%
190.46
Last update: 05/18/2024

Highest Price Target 8.40€

Average Price Target 7.00€

Lowest Price Target 2.25€

Innate Pharma Stock Predictions 2025

Stock Forecast for the Price of an Innate Pharma Share in Jan 2025.

In January 2025, analysts believe the stock price will be 2.57€. An increase of 6.63% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Feb 2025.

In February 2025, analysts believe the stock price will be 2.59€. An increase of 7.46% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Mar 2025.

In March 2025, analysts believe the stock price will be 2.61€. An increase of 8.28% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Apr 2025.

In April 2025, analysts believe the stock price will be 2.63€. An increase of 9.11% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in May 2025.

In May 2025, analysts believe the stock price will be 2.65€. An increase of 9.93% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Jun 2025.

In June 2025, analysts believe the stock price will be 2.67€. An increase of 10.76% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Jul 2025.

In July 2025, analysts believe the stock price will be 2.69€. An increase of 11.58% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Aug 2025.

In August 2025, analysts believe the stock price will be 2.71€. An increase of 12.41% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Sep 2025.

In September 2025, analysts believe the stock price will be 2.73€. An increase of 13.24% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Oct 2025.

In October 2025, analysts believe the stock price will be 2.75€. An increase of 14.06% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Nov 2025.

In November 2025, analysts believe the stock price will be 2.77€. An increase of 14.89% compared to the previous month's estimate.

Stock Forecast for the Price of an Innate Pharma Share in Dec 2025.

In December 2025, analysts believe the stock price will be 2.79€. An increase of 15.71% compared to the previous month's estimate.

Innate Pharma Stock Prediction 2030

Stock Prediction for the Price of One Innate Pharma Share in Jan 2030.

In Jan 2030 analysts predict a share price of 4.02€. An increase of 66.79% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Feb 2030.

In Feb 2030 analysts predict a share price of 4.05€. An increase of 68.09% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Mar 2030.

In Mar 2030 analysts predict a share price of 4.08€. An increase of 69.38% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Apr 2030.

In Apr 2030 analysts predict a share price of 4.11€. An increase of 70.67% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in May 2030.

In May 2030 analysts predict a share price of 4.14€. An increase of 71.96% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Jun 2030.

In Jun 2030 analysts predict a share price of 4.18€. An increase of 73.25% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Jul 2030.

In Jul 2030 analysts predict a share price of 4.21€. An increase of 74.54% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Aug 2030.

In Aug 2030 analysts predict a share price of 4.24€. An increase of 75.83% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Sep 2030.

In Sep 2030 analysts predict a share price of 4.27€. An increase of 77.12% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Oct 2030.

In Oct 2030 analysts predict a share price of 4.30€. An increase of 78.41% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Nov 2030.

In Nov 2030 analysts predict a share price of 4.33€. An increase of 79.7% compared to today's share price.

Stock Prediction for the Price of One Innate Pharma Share in Dec 2030.

In Dec 2030 analysts predict a share price of 4.36€. An increase of 81% compared to today's share price.

P/E
0.00
Beta
0.66
Price-to-book Ratio
3.77
Market Cap
0.20B
TEV
0.14 B
Dividend
0.00€
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
6.32€
Country

Innate Pharma Analyst Ratings Frequently Asked Questions

Who are the analysts watching Innate Pharma S.A.?

The following analysts have recently covered Innate Pharma:

Bryan Garnier & Co
Citigroup Inc
Evercore ISI
Goldman Sachs
H.C. Wainwright & Co.
Kepler Cheuvreux
ODDO BHF Corporate & Markets
Leerink Partners LLC
Stifel
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Innate Pharma S.A.?

The following sell-side analysts have recently covered Innate Pharma:

Nochomovitz, Yigal Dov
Bayko, Liisa Ann
Ramakanth, Swayampakula
Denguir, Oussema
Graybosch, Daina Michelle
Telliez, Justine
Le Berrigaud, Eric
Haffen Lamm, Oscar
Hallatt, Nicholas
(This information refers to the last 90 days.)